Knight Therapeutics (TSE:GUD) Stock Price Up 2% – Time to Buy?

Shares of Knight Therapeutics Inc. (TSE:GUD) were up 2% on Monday . The stock traded as high as C$9.70 and last traded at C$9.66. 55,797 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 96,049 shares. The stock had previously closed at C$9.47.

Analyst Ratings Changes

Separately, Canaccord Genuity Group set a C$9.50 price target on Knight Therapeutics and gave the company a “buy” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of C$9.50.

Knight Therapeutics Stock Up 2.0%

The firm has a market cap of C$948.92 million, a P/E ratio of 64.40, a P/E/G ratio of -1,013.50 and a beta of -0.19. The business’s fifty day moving average price is C$9.68 and its two-hundred day moving average price is C$8.29. The company has a current ratio of 2.28, a quick ratio of 1.79 and a debt-to-equity ratio of 4.29.

Knight Therapeutics (TSE:GUD) last released its quarterly earnings data on Thursday, August 6th. The company reported C($0.03) earnings per share (EPS) for the quarter. The business had revenue of C$143.97 million during the quarter. Knight Therapeutics had a net margin of 2.72% and a return on equity of 1.91%. As a group, equities research analysts anticipate that Knight Therapeutics Inc. will post 0.1009486 EPS for the current year.

About Knight Therapeutics

Knight Therapeutics Inc, headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc’s shares trade on the TSX under the symbol GUD. For more information about Knight Therapeutics Inc, please visit the company’s web site at www.knighttx.com or www.sedarplus.ca.